The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce, according to Modern Healthcare. Noncompete agreements were used in about 40% of physician employment contracts to restrict employees from working in a specific geographic area or for a rival organization; such provisions are also common in the insurance and pharmacy benefit manager industries. Previously, noncompete agreements were governed by various state laws. Under the FTC’s final rule, employers are prevented from issuing noncompete agreements for new hires and from enforcing them in existing contracts, the only exception being senior executives. The FTC estimates the rule will reduce spending on physician services by up to $194 billion over the new decade, boost wages by up to $488 billion over the next decade, and create 8500 jobs per year. This rule is set to take effect 120 days after it is published in the Federal Register, but implementation may be delayed by litigation as organizations are expected to sue to block the regulation; the US Chamber of Commerce is expected to file a lawsuit to block the rule, and some employers may do the same.
A recent study published in the American Economic Review reported that federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs, according to Axios. The researchers found that the FTC only took enforcement action against 13 (1%) of the 1164 acute-care hospital mergers between 2002 and 2020. As a result, health care prices increased at least 5% between 2010 and 2015 due to mergers that the FTC could have flagged as anticompetitive. More specifically, based on the agency’s tools for screening mergers that could reduce competition and raise prices, the FTC could have flagged 238 (20%) mergers. In particular, mergers in rural and lower-income regions increased hospital prices more than those in other regions, furthering health inequities. The researchers attributed this lax enforcement to the underfunding of the FTC as its average annual enforcement budget between 2010 and 2015 was $136 million. Meanwhile, during that same period, hospital mergers raised health spending for privately insured people by $204 million on average.
The FDA announced Tuesday that it found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk, according to Stat. However, the testing, done by polymerase chain reaction (PCR), cannot distinguish between live virus or virus fragments that could have been killed during the pasteurization process. The FDA explained that it has been trying to grow virus from milk found to contain evidence of H5N1 as that is the best way to see if there is viable virus in a product. The FDA said it believes that the pasteurization process very likely inactivates H5N1, and that commercial, pasteurized milk is safe to consume. However, their statement did not indicate if the testing suggested the amounts of viral genetic material in the milk were high or low; it also did not reveal if the milk products were purchased where outbreaks have occurred or elsewhere. To answer these questions and beyond, the FDA said it is testing milk from store shelves and the processing system to produce a large representative national sample of the milk supply, which could help to construct a more robust picture of H5N1’s spread national spread among dairy cows.
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Covering antiobesity medications like semaglutide could save Medicare around $500 million annually; preliminary CDC data showed a 3% decline in the number of US overdose deaths last year; the Biden administration recently announced the first national maternal mental health strategy.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More
Panel Addresses Minority Physician Shortage, Maternal Health at Senate Committee Hearing
May 15th 2024The senate hearing held by the US Senate Committee on Health, Education, Labor, and Pensions, led by Sen. Bernie Sanders (I, Vermont), chairman of the committee, and ranking member Sen. Bill Cassidy, MD, (R, Louisiana), addressed the critical issue of physician and health care worker shortages, as well as the maternal health crisis, in the US.
Read More